Page 207 - Read Online
P. 207

Page 12 of 13                            Salas et al. J Cancer Metastasis Treat 2018;4:15  I  http://dx.doi.org/10.20517/2394-4722.2017.66


                   Filho V, Franceschi S, Hayes RB, Herrero R, Koifman S, La Vecchia C, Lazarus P, Levi F, Mates D, Matos E, Menezes A, Muscat J, Eluf-
                   Neto J, Olshan AF, Rudnai P, Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Zaridze D,
                   Zatonski W, Zhang ZF, Berthiller J, Boffetta P. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the
                   risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst
                   2007;99:777-89.
               12.  Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R,
                   Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med
                   2010;363:24-35.
               13.  Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human
                   papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-9.
               14.  Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang
                   MB, Srivatsan ES. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
                   Laryngoscope 2002;112:472-81.
               15.  Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Sasaki C, Rimm DL, Psyrri A. Prognostic significance of p16 protein levels
                   in oropharyngeal squamous cell cancer. Clin Cancer Res 2004;10:5684-91.
               16.  Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J. Effect of HPV-associated p16INK4A expression on response
                   to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009;27:1992-8.
               17.  Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a
                   systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-75.
               18.  Evans JF, Shah JP. Epidermoid carcinoma of the palate. Am J Surg 1981;142:451-5.
               19.  Cady B, Catlin D. Epidermoid carcinoma of the gum. A 20-year survey. Cancer 1969;23:551-69.
               20.  Hiratsuka H, Miyakawa A, Nakamori K, Kido Y, Sunakawa H, Kohama G. Multivariate analysis of occult lymph node metastasis as a
                   prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer 1997;80:351-6.
               21.  Wallwork BD, Anderson SR, Coman WB. Squamous cell carcinoma of the floor of the mouth: tumour thickness and the rate of cervical
                   metastasis. ANZ J Surg 2007;77:761-4.
               22.  Pitman KT. Rationale for elective neck dissection. Am J Otolaryngol 2000;21:31-7.
               23.  Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol
                   Head Neck Surg 1994;120:699-702.
               24.  Haddadin KJ, Soutar DS, Oliver RJ, Webster MH, Robertson AG, MacDonald DG. Improved survival for patients with clinically T1/T2,
                   N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999;21:517-25.
               25.  Yuen AP, Wei WI, Wong YM, Tang KC. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma.
                   Head Neck 1997;19:583-8.
               26.  Capote A, Escorial V, Munoz-Guerra MF, Rodriguez-Campo FJ, Gamallo C, Naval L. Elective neck dissection in early-stage oral
                   squamous cell carcinoma--does it influence recurrence and survival? Head Neck 2007;29:3-11.
               27.  Janeway HH. The treatment of tumors of the superior maxilla. Ann Surg 1918;68:353.
               28.  Martin H. Cancer of the gums (gingivae). Am J Surg (Special Monograph) 1941;54:770-806.
               29.  Soo KC, Spiro RH, King W, Harvey W, Strong EW. Squamous carcinoma of the gums. Am J Surg 1988;156:281-5.
               30.  Evans JF, Shah JP. Epidermoid carcinoma of the palate. Am J Surg 1981;142:451-5.
               31.  Joe JK, Patel SG, Shaha AR. Management of the neck. In: Rhys Evans PH, Montgomery PQ, Gullane PJ, editors. Principles and Practices
                   of Head and Neck Surgery and Oncology. London and New York: Taylor & Francis; 2003. p. 534-73.
               32.  Sparano A, Weinstein G, Chalian A, Yodul M, Weber R. Multivariate predictors of occult neck metastasis in early oral tongue cancer.
                   Otolaryngol Head Neck Surg 2004;131:472-6.
               33.  Pentenero M, Gandolfo S, Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral
                   squamous cell carcinoma: a review of the literature. Head Neck 2005;27:1080-91.
               34.  Andersen PE, Cambronero E, Shaha AR, Shah JP. The extent of neck disease after regional failure during observation of the N0 neck. Am
                   J Surg 1996;172:689-91.
               35.  Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, Karavidas K, Jay A, Sandison A, Thomas GJ, Kalavrezos N, Hopper
                   C. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.
                   Head Neck Oncol 2010;2:1.
               36.  Os AD, Karakullukcu B, Leemans CR, Halmos GB, Roodenburg JL, Weert SV, Karagozoglu KH, Witjes MJ. Management of the
                   clinically N0 neck in squamous cell carcinoma of the maxillary alveolus and hard palate. Head Neck 2016;38:1794-8.
               37.  Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg
                   Oral Med Oral Pathol Oral Radiol Endod 2006;102:67-76.
               38.  Jones HB, Sykes A, Bayman N, Sloan P, Swindell R, Patel M, Musgrove B. The impact of lymphovascular invasion on survival in oral
                   carcinoma. Oral Oncol 2009;45:10-5.
               39.  Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence. Cancer 2007;110:1429-35.
               40.  D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human
                   papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56.
               41.  Worden FP, Kumar B, Lee JS, Wolf GT, Cordell KG, Taylor JM, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, Prince ME, Tsien
                   CI, D’Silva NJ, Yang K, Kurnit DM, Mason HL, Miller TH, Wallace NE, Bradford CR, Carey TE. Chemoselection as a strategy for
                   organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol
                   2008;26:3138-46.
               42.  Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly
   202   203   204   205   206   207   208   209   210   211   212